Founded in Argyle, Texas, Equine Amnio Solutions is dedicated to pioneering regenerative veterinary solutions aimed at enhancing the health and performance of horses across all breeds and sports. The company's core mission is to provide cutting-edge, science-backed products that support equine well-being. Their flagship product, RenoVō®, is an acellular, cryopreserved, liquid allograft derived from equine birth tissues, designed to offer advanced therapeutic benefits for equine use.
Equine Amnio Solutions has garnered attention from notable figures in the veterinary and equestrian communities, along with significant investment from industry leaders. The company has achieved key milestones, including successful clinical studies and widespread adoption of RenoVō® in various equestrian disciplines. Their innovative approach has made a substantial impact on the field of veterinary medicine, setting new standards for equine care and performance enhancement.
